Advertisement
Sinopharm Tech Holdings Limited

Sinopharm Tech Holdings Limited (8156.HK) Stock Competitors & Peer Comparison

See (8156.HK) competitors and their performances in Stock Market.

8156.HKHKSE
TechnologySoftware - Application
HK$0.22
HK$0.001(0.46%)
Hong Kong Market opens in 15h 3m
Advertisement

Peer Comparison Table: Software - Application Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
8156.HKHK$0.22+3.81%138.1M21.80HK$0.01N/A
0020.HKHK$1.45-2.03%58B-24.17-HK$0.06N/A
9660.HKHK$4.15-1.89%52B-4.41-HK$0.94N/A
6651.HKHK$99.80-1.58%39.4B-178.21-HK$0.56N/A
2723.HKHK$330.20+10.14%29.9B2751.67HK$0.12N/A
2026.HKHK$63.95+0.24%27.7B-23.34-HK$2.74N/A
3896.HKHK$5.14-2.10%23.1B-19.04-HK$0.27N/A
9899.HKHK$107.30-3.25%22.7B7.19HK$14.92N/A
0268.HKHK$6.29-2.48%22B209.67HK$0.03N/A
0800.HKHK$16.72-1.94%16.6B-8.44-HK$1.98N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

8156.HK vs 0020.HK Comparison June 2026

8156.HK plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 8156.HK stands at 138.1M. In comparison, 0020.HK has a market cap of 58B. Regarding current trading prices, 8156.HK is priced at HK$0.22, while 0020.HK trades at HK$1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

8156.HK currently has a P/E ratio of 21.80, whereas 0020.HK's P/E ratio is -24.17. In terms of profitability, 8156.HK's ROE is -0.10%, compared to 0020.HK's ROE of -0.07%. Regarding short-term risk, 8156.HK is less volatile compared to 0020.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 8156.HK.Check 0020.HK's competition here

Stock price comparison of stocks in the Technology Sector

Loading...

Frequently Asked Questions